These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Diabetic macular edema treated with ranibizumab following bevacizumab failure in Israel (DERBI study). Ehrlich R; Pokroy R; Segal O; Goldstein M; Pollack A; Hanhart J; Barak Y; Kehat R; Shulman S; Vidne O; Abu Ahmad W; Chowers I Eur J Ophthalmol; 2019 Mar; 29(2):229-233. PubMed ID: 29916263 [TBL] [Abstract][Full Text] [Related]
23. COMBINED INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA: Two-Year Randomized Single-Blind Controlled Trial Results. Lafuente M; Ortín L; Argente M; Guindo JL; López-Bernal MD; López-Román FJ; García MJ; Domingo JC; Lajara J Retina; 2017 Jul; 37(7):1277-1286. PubMed ID: 27787443 [TBL] [Abstract][Full Text] [Related]
24. Ranibizumab for the Treatment of Diabetic Macular Oedema in the Real-World Clinical Setting in Portugal: A Multicentre Study. Farinha C; Martins A; Neves A; Soares R; Ruão M; Ornelas M; Neves P; Gomes Rodrigues F; Coelho C; Silva R Ophthalmologica; 2019; 241(1):1-8. PubMed ID: 29886497 [TBL] [Abstract][Full Text] [Related]
25. LONG-TIME OUTCOME IN PATIENTS TREATED WITH RANIBIZUMAB FOR DIABETIC MACULAR EDEMA: A 4-Year Study. Epstein D; Amrén U Retina; 2018 Jan; 38(1):183-186. PubMed ID: 28323678 [TBL] [Abstract][Full Text] [Related]
27. Comparison of efficacy of intravitreal ranibizumab between non-vitrectomized and vitrectomized eyes with diabetic macular edema. Chen YY; Chen PY; Chen FT; Chen YJ; Wang JK Int Ophthalmol; 2018 Feb; 38(1):293-299. PubMed ID: 28176171 [TBL] [Abstract][Full Text] [Related]
31. Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting. Patrao NV; Antao S; Egan C; Omar A; Hamilton R; Hykin PG; Sivaprasad S; Rajendram R; Am J Ophthalmol; 2016 Dec; 172():51-57. PubMed ID: 27637784 [TBL] [Abstract][Full Text] [Related]
32. Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice. Holekamp NM; Campbell J; Almony A; Ingraham H; Marks S; Chandwani H; Cole AL; Kiss S Am J Ophthalmol; 2018 Jul; 191():83-91. PubMed ID: 29684329 [TBL] [Abstract][Full Text] [Related]
33. Outcomes after a 1-Year Treatment with Ranibizumab for Diabetic Macular Edema in a Clinical Setting. Hrarat L; Fajnkuchen F; Boubaya M; Lévy V; Sarda V; Grenet T; Nghiem-Buffet S; Chaine G; Giocanti-Auregan A Ophthalmologica; 2016; 236(4):207-214. PubMed ID: 27898414 [TBL] [Abstract][Full Text] [Related]